(FDA) Advisory Panel Favors Approval for Weight-Loss Drug (Qnexa)
Source: New York Times
Advisory Panel Favors Approval for Weight-Loss Drug
By ANDREW POLLACK
Published: February 22, 2012
A federal advisory panel on Wednesday overwhelmingly recommended approval of what could become the first new prescription drug to treat obesity in 13 years.
The advisory committee to the Food and Drug Administration voted 20 to 2 that the benefits of the drug in causing weight loss more than offset the potential risks of heart problems and birth defects.
The drug, called Qnexa, was developed by Vivus, a small company in Mountain View, Calif.
The same committee, though with somewhat different composition, voted 10 to 6 not to recommend approval of the drug in 2010. The F.D.A. itself then declined to approve the drug.
[font size=1]
-snip-[/font]
Read more:
http://www.nytimes.com/2012/02/23/business/fda-advisory-panel-backs-diet-drug.html